What it does / how it works
Turns on GLP-1 and glucagon receptors. GLP-1 reduces intake. Glucagon increases energy expenditure and hepatic fat oxidation. Weekly fatty-acid tail keeps it in circulation.
| Class | GLP-1 / glucagon dual agonist |
| Typical vial | 10 mg |
| Reconstitution | 1–2 mL BAC water |
| Storage after mix | 2–8°C, use within 28 days |
Protocol
| Goal | Dose | How often | How long | Route |
| Weeks 1-4 start | 1.5-2 mg | Once weekly | 4 weeks | SubQ |
| China Phase 2 targets | 3, 4.5 or 6 mg | Once weekly | 24 weeks | SubQ |
| US Phase 2 higher arms | 10 mg or 16 mg after titration | Once weekly | 32-48 weeks | SubQ |
Watch: Treat like any weekly incretin: titrate.